Phillip Dolamore
Geen lopende functies
Loopbaan van Phillip Dolamore
Eerdere bekende functies van Phillip Dolamore
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| Glaxo, Inc. | Corporate Officer/Principal | - | - |
| GlaxoWellcome /Pharmocology Unit/ | Corporate Officer/Principal | - | - |
GlycoForm Ltd.
 GlycoForm Ltd. Pharmaceuticals: MajorHealth Technology Glycoform Ltd. develops pharmaceutical products. The firm's novel synthetic glycoprotein, GLY510, is designed for the treatment of anemia. It provides services in the areas of therapeutic proteins, drug targeting using glycosylation, and enzyme activated pro-drug technology. The company was founded by Benjamin G. Davis and Antony J. Fairbanks in November 2002 and is headquartered in Abingdon, UK | Corporate Officer/Principal | 01-01-2008 | - |
Statistieken
Internationaal
| Verenigd Koninkrijk | 3 |
| Canada | 2 |
Operationeel
| Corporate Officer/Principal | 3 |
Sectoraal
| Health Technology | 2 |
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
GlycoForm Ltd.
GlycoForm Ltd. Pharmaceuticals: MajorHealth Technology Glycoform Ltd. develops pharmaceutical products. The firm's novel synthetic glycoprotein, GLY510, is designed for the treatment of anemia. It provides services in the areas of therapeutic proteins, drug targeting using glycosylation, and enzyme activated pro-drug technology. The company was founded by Benjamin G. Davis and Antony J. Fairbanks in November 2002 and is headquartered in Abingdon, UK | Health Technology |
| Glaxo, Inc. | |
| GlaxoWellcome /Pharmocology Unit/ | Commercial Services |
- Beurs
- Insiders
- Phillip Dolamore
- Ervaring
